case study OptiForm ‰ Solution Suite Accelerates Bioavailability Enhancement for Early Phase Molecule Executive Summary A biotech company developed an extremely poorly soluble new molecule in pre-clinical phase. Catalent provided a structured approach with its new offering OptiForm ‰ Solution Suite, to help select the most suitable formulation technology to enhance the molecule’s bioavailability. In just 12 weeks, experts at Catalent co

Join for free to read